AEMPS
- Local brand name: Bosulif
- Status: approved
Bosulif (bosutinib) regulatory status in Spain.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. AEMPS has authorised it.
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.